MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $76,000 | -54.2% | 61,383 | +14.1% | 0.00% | – |
| Q1 2017 | $166,000 | -8.3% | 53,779 | +21.5% | 0.00% | – |
| Q4 2016 | $181,000 | -39.1% | 44,264 | -5.3% | 0.00% | -100.0% |
| Q3 2016 | $297,000 | +23.2% | 46,764 | +4.5% | 0.00% | 0.0% |
| Q2 2016 | $241,000 | -38.4% | 44,764 | -4.1% | 0.00% | 0.0% |
| Q1 2016 | $391,000 | +43.2% | 46,664 | +35.3% | 0.00% | 0.0% |
| Q4 2015 | $273,000 | -22.4% | 34,500 | -16.7% | 0.00% | 0.0% |
| Q3 2015 | $352,000 | -33.6% | 41,400 | -3.5% | 0.00% | -50.0% |
| Q2 2015 | $530,000 | +19.9% | 42,900 | +15.3% | 0.00% | 0.0% |
| Q1 2015 | $442,000 | – | 37,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |